{"id":41762,"date":"2023-08-30T09:10:28","date_gmt":"2023-08-30T07:10:28","guid":{"rendered":"https:\/\/www.invarena.cz\/?p=41762"},"modified":"2023-08-30T09:10:35","modified_gmt":"2023-08-30T07:10:35","slug":"onkologove-predstavili-imunoterapii-boj-s-rakovinou-je-diky-ni-uspesnejsi","status":"publish","type":"post","link":"https:\/\/www.invarena.cz\/?p=41762","title":{"rendered":"Onkologov\u00e9 p\u0159edstavili imunoterapii. Boj s\u00a0rakovinou je d\u00edky n\u00ed \u00fasp\u011b\u0161n\u011bj\u0161\u00ed"},"content":{"rendered":"\n

Imunoterapie a dal\u0161\u00ed modern\u00ed l\u00e9\u010debn\u00e9 postupy m\u011bn\u00ed rakovinu na chronick\u00e9 onemocn\u011bn\u00ed. Upozornili na to \u010de\u0161t\u00ed onkologov\u00e9 a pacientsk\u00e9 spolky. Poskytuj\u00ed ji Komplexn\u00ed onkologick\u00e1 centra (KOC), v\u00a0nich\u017e se na l\u00e9\u010db\u011b pod\u00edl\u00ed t\u00fdmy specialist\u016f z\u00a0r\u016fzn\u00fdch obor\u016f. <\/strong><\/p>\n\n\n\n

Prof. MUDr. Michael Doubek, z\u00e1stupce p\u0159ednosty Intern\u00ed hematologick\u00e9 a onkologick\u00e9 kliniky LF Masarykovy univerzity vyzdvihl p\u0159\u00ednos imunoterapie pro hematoonkologii. \u201eJsme sv\u011bdky toho, \u017ee modern\u00ed l\u00e9\u010dba \u2013 a\u0165 u\u017e jsou to protil\u00e1tky proti n\u00e1dorov\u00fdm bu\u0148k\u00e1m, nebo imunoterapie \u2013 pacient\u016fm s\u00a0konkr\u00e9tn\u00edmi krevn\u00edmi nemocemi v\u00fdznamn\u011b prodlou\u017eila p\u0159e\u017eit\u00ed,\u201c uvedl.<\/p>\n\n\n\n

\u201ePokud jde o imunoterapii, vyu\u017e\u00edv\u00e1me specifick\u00fd typ b\u00edl\u00fdch krvinek. Separujeme je z t\u011bla pacienta a geneticky je pozm\u011bn\u00edme tak, aby se nau\u010dily rozpozn\u00e1vat ur\u010dit\u00fd znak v n\u00e1dorov\u00fdch bu\u0148k\u00e1ch. Po n\u011bjak\u00e9 dob\u011b se takto upraven\u00e9 lymfocyty vr\u00e1t\u00ed zp\u011bt pacientovi do krevn\u00edho ob\u011bhu, aby mohly zni\u010dit n\u00e1dorov\u00e9 bu\u0148ky. Tato n\u00e1ro\u010dn\u00e1 l\u00e9\u010dba je vhodn\u00e1 p\u0159edev\u0161\u00edm u nemocn\u00fdch s lymfomy a s n\u011bkter\u00fdmi typy akutn\u00edch leuk\u00e9mi\u00ed, kte\u0159\u00ed maj\u00ed velmi odoln\u00e9 onemocn\u011bn\u00ed a jin\u00e9 l\u00e9ky u\u017e u nich nefunguj\u00ed,\u201c dodal.<\/p>\n\n\n\n

P\u0159edsedkyn\u011b \u010cesk\u00e9 onkologick\u00e9 spole\u010dnosti doc. Jana Prausov\u00e1 doplnila, \u017ee imunoterapie a dal\u0161\u00ed v\u00fdzkum v l\u00e9\u010db\u011b onkologick\u00fdch onemocn\u011bn\u00ed d\u00e1vaj\u00ed do budoucna velkou nad\u011bji, \u017ee ob\u00e1van\u00e9 diagn\u00f3zy se dostanou do kategorie chronick\u00fdch, nikoliv fat\u00e1ln\u00edch onemocn\u011bn\u00ed. P\u0159esto by lid\u00e9 nem\u011bli zapom\u00ednat na zdrav\u00fd \u017eivotn\u00ed styl a prevenci. \u201eV \u010cesk\u00e9 republice m\u00e1me pro n\u011bkolik nej\u010dast\u011bj\u0161\u00edch typ\u016f n\u00e1dor\u016f bezplatn\u00e9 screeningov\u00e9 programy. Z praxe v\u00edme, \u017ee v\u010dasn\u00fd z\u00e1chyt skute\u010dn\u011b zvy\u0161uje \u0161anci na vyl\u00e9\u010den\u00ed. To je jednozna\u010dn\u00fd argument pro to, aby lid\u00e9 tyto programy vyu\u017e\u00edvali,\u201c uvedla.<\/p>\n\n\n\n

Do budoucna by r\u00e1da vid\u011bla je\u0161t\u011b t\u011bsn\u011bj\u0161\u00ed spolupr\u00e1ci praktick\u00fdch l\u00e9ka\u0159\u016f s Komplexn\u00edmi onkologick\u00fdmi centry. \u201ePrakti\u010dt\u00ed l\u00e9ka\u0159i jsou v prvn\u00ed linii \u2013 u nic cel\u00fd proces za\u010d\u00edn\u00e1. Pokud existuje podez\u0159en\u00ed na n\u00e1dorov\u00e9 onemocn\u011bn\u00ed je d\u016fle\u017eit\u00e9, aby l\u00e9ka\u0159 pacienta odeslal co nejd\u0159\u00edve do Komplexn\u00edho onkologick\u00e9ho centra, kde je adekv\u00e1tn\u011b vy\u0161et\u0159en a diagnostikov\u00e1n. T\u00fdm odborn\u00edk\u016f r\u016fzn\u00fdch specializac\u00ed pak ur\u010d\u00ed optim\u00e1ln\u00ed postup,\u201c popsala onkolo\u017eka.<\/p>\n\n\n\n

Onkologick\u00fd pacient\u016fm a jejich bl\u00edzk\u00fdm pom\u00e1haj\u00ed v n\u00e1ro\u010dn\u00e9m procesu l\u00e9\u010dby tak\u00e9 pacientsk\u00e9 spolky. Petra Ad\u00e1mkov\u00e1 z Hlasu onkologick\u00fdch pacient\u016f vn\u00edm\u00e1 jako z\u00e1sadn\u00ed, aby pacienti m\u011bli dostatek informac\u00ed. I proto se spolek HOP p\u0159ipojil ke kampani Dotek, kter\u00fd pom\u00e1h\u00e1. \u201eNa\u0161\u00ed zku\u0161enost\u00ed je, \u017ee lid\u00e9 \u010dasto nev\u011bd\u00ed, jak\u00e9 jsou jejich mo\u017enosti, na co maj\u00ed n\u00e1rok, nev\u011bd\u00ed, kam se maj\u00ed obracet o radu v praktick\u00fdch z\u00e1le\u017eitostech. Proto jsme, r\u00e1di, \u017ee jsme se mohli pod\u00edlet na tom, aby se o imunoterapii dozv\u011bd\u011bly tis\u00edce lid\u00ed, by\u0165 bych jim p\u0159\u00e1la, aby ji nikdy nepot\u0159ebovali,\u201c podotkla.<\/p>\n\n\n\n

<\/a> <\/h2>\n\n\n\n
Jak funguj\u00ed modern\u00ed terapie v onkologii?<\/a>   Modern\u00ed terapie, a zvl\u00e1\u0161t\u011b imunoterapie, m\u011bn\u00ed doned\u00e1vna prakticky stoprocentn\u011b smrteln\u00e9 rychle progreduj\u00edc\u00ed onemocn\u011bn\u00ed v chronickou chorobu, a to vybuzen\u00edm imunitn\u00edho syst\u00e9mu pacienta, kter\u00fd je pak schopen efektivn\u011bji bojovat s onkologick\u00fdm n\u00e1dorem. \u010c\u00e1st pacient\u016f d\u00edky imunoterapii nad rakovinou zv\u00edt\u011bz\u00ed. Modern\u00ed l\u00e9\u010dba v\u0161ak d\u00e1v\u00e1 nad\u011bji i t\u011bm pacient\u016fm, kte\u0159\u00ed na l\u00e9\u010dbu neodpov\u011bd\u00ed optim\u00e1ln\u011b, proto\u017ee zvy\u0161uje jejich \u0161anci do\u017e\u00edt se dal\u0161\u00edho pokroku a nov\u00fdch l\u00e9\u010debn\u00fdch metod.   Konkr\u00e9tn\u00ed p\u0159\u00edklad lze sledovat t\u0159eba u melanomu, tedy onkologick\u00e9ho onemocn\u011bn\u00ed k\u016f\u017ee. Stagnace onemocn\u011bn\u00ed \u010di pokles mortality je jednozna\u010dn\u011b zp\u016fsoben p\u0159\u00edchodem vysoce \u00fa\u010dinn\u00fdch metod l\u00e9\u010dby, jak do adjuvantn\u00ed f\u00e1ze l\u00e9\u010dby, tak do l\u00e9\u010dby metastatick\u00e9ho onemocn\u011bn\u00ed.   Zat\u00edmco je\u0161t\u011b v ned\u00e1vn\u00e9 dob\u011b p\u0159e\u017e\u00edvali pacienti s metastatick\u00fdm melanomem pr\u016fm\u011brn\u011b 6 a\u017e 8 m\u011bs\u00edc\u016f od diagn\u00f3zy a pouh\u00e1 \u010dtvrtina takov\u00fdch pacient\u016f \u017eila d\u00e9le ne\u017e jeden rok, dnes se d\u00edky v\u00fdsledk\u016fm klinick\u00fdch studi\u00ed ukazuje, \u017ee a\u017e 50 % pacient\u016f s touto diagn\u00f3zou m\u016f\u017ee \u017e\u00edt i v\u00edce ne\u017e 6 let po zah\u00e1jen\u00ed l\u00e9\u010dby imunoterapi\u00ed a s dobrou perspektivou dal\u0161\u00edho p\u0159e\u017eit\u00ed.<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"

Imunoterapie a dal\u0161\u00ed modern\u00ed l\u00e9\u010debn\u00e9 postupy m\u011bn\u00ed rakovinu na chronick\u00e9 onemocn\u011bn\u00ed. Upozornili na to \u010de\u0161t\u00ed onkologov\u00e9 a pacientsk\u00e9 spolky. Poskytuj\u00ed ji Komplexn\u00ed onkologick\u00e1 centra (KOC), […]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":18908,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-41762","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zdravi"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/41762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=41762"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/41762\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/media\/18908"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=41762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=41762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=41762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}